Genetic Engineering for Diabetes: From Recombinant Insulin to Genome-Edited Beta-Cell Replacement
Abstract
Genetic Engineering for Diabetes explores the scientific principles, emerging technologies, and potential applications of genetic engineering in the prevention, understanding, and treatment of diabetes mellitus. The work introduces the genetic and molecular mechanisms associated with diabetes, including the roles of inherited susceptibility, gene regulation, pancreatic beta-cell function, insulin production, and glucose metabolism. The publication examines how advances in genetic engineering, genome editing, molecular biology, stem-cell research, and biotechnology may contribute to a better understanding of diabetes and the development of future therapeutic approaches. It discusses research directions involving pancreatic beta-cell regeneration, cellular replacement strategies, genetic studies of diabetes susceptibility, and the potential use of advanced biological technologies to improve glucose regulation. The work also addresses the scientific challenges, safety considerations, ethical questions, and regulatory requirements associated with genetic interventions. Particular attention is given to the distinction between established diabetes treatments, experimental approaches under investigation, and potential future applications that require further laboratory research and clinical evaluation. This publication is intended as an educational and research-oriented resource for students, researchers, educators, biotechnology professionals, endocrinology specialists, and readers interested in the intersection of genetic engineering and diabetes research. Its overall objective is to encourage scientific understanding, responsible innovation, and further investigation into how genetic and molecular technologies may contribute to future advances in diabetes care.
